BSE · 542771
Novateor Research Laboratories Ltd.
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹3 Cr with net profit ₹0 Cr — a 2.51% net margin, versus 1.73% the period before.
Shareholding
As of 2026-03-31
- Promoter50.75%
- Public49.25%
172 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 2.45× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Personal Care - Indian · ranked #12 of 14 by market cap · medians across 12 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Godrej Consumer Products Ltd. | ₹1,10,009 Cr | 243.24 | 8.69 | 14.71% | 12.16% |
| Lenskart Solutions Ltd. | ₹97,673 Cr | 480.13 | 11.16 | 5.65% | 5.6% |
| Dabur India Ltd. | ₹76,732 Cr | 207.96 | 6.72 | 16.59% | 14.36% |
| Cupid Limited | ₹31,414 Cr | 865.26 | 69.69 | 24.01% | 30.26% |
| Emami Limited | ₹17,840 Cr | 124.6 | 6.1 | 26.51% | 20.51% |
| Jyothy Labs Limited | ₹7,581 Cr | 112.2 | 4.77 | 18.07% | 13.01% |
| Bajaj Consumer Care Ltd. | ₹7,002 Cr | 112.86 | 9.27 | 25.19% | 16.49% |
| Radix Industries (India) Ltd. | ₹225 Cr | 77 | 9.67 | 13.72% | 6.41% |
| Thrive Future Habitats Limited | ₹96 Cr | — | 1.81 | -1.94% | -85.25% |
| JHS Svendgaard Laboratories Ltd. | ₹65 Cr | — | 0.37 | -1.1% | -1.89% |
| Novateor Research Laboratories Ltd.(this company) | ₹20 Cr | 193.24 | 1.78 | 0.88% | 0% |
AI analysis
AI-generated · google/gemini-2.5-flashNovateor Research Laboratories Ltd. is listed with a market capitalization of Rs 20 Cr. The company reported a revenue of Rs 3.25 Cr, an EPS of 0.17, and a PE ratio of 193.24.
Positives
- +The debt-to-equity ratio of 0.11 is low, indicating limited reliance on borrowed capital.
- +The Return on Equity (ROE) is high at 88% based on the latest available data.
- +The Net Profit increased from Rs 0.03 Cr in March 2024 to Rs 0.08 Cr in March 2025.
Negatives
- −The trailing twelve-month PE ratio of 193.24 is high, suggesting a premium valuation.
- −The profit margin is 0%, indicating very low profitability relative to revenue.
- −Promoter holding decreased from 60.8735% in March 2023 to 50.7542% in March 2026.
- −The company has not disclosed quarterly results since March 2025.
Financial Performance
Novateor Research Laboratories Ltd. reported revenue of Rs 3.25 Cr for the fiscal year ending March 2025. This compares to a revenue of Rs 1.69 Cr in March 2024. The net profit for March 2025 was Rs 0.08 Cr, an increase from Rs 0.03 Cr in March 2024.
Profitability & Returns
The company's Return on Equity (ROE) stands at 88%. The Return on Capital Employed (ROCE) is 1.592%. The profit margin is 0% for the latest period. The EPS was 0.17, with a PE ratio of 193.24.
Balance Sheet
Novateor Research Laboratories Ltd. has a book value of Rs 18.51. The debt-to-equity ratio is 0.11, indicating a low level of debt relative to equity. There is no dividend yield reported for the company.
Ownership & Pledges
As of March 31, 2026, promoter holding in Novateor Research Laboratories Ltd. was 50.7542%. Public shareholding was 49.2458%. There is no promoter pledging reported as of the same date. The number of shareholders is 172.
Data as of — price: 2026-07-29 · financials: Mar 25 · shareholding: Mar 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.
Back to Novateor Research Laboratories Ltd.share price & fundamentals